Last Update: 10/27/2026 at 6:00 AM EST

DNA Testing Privacy Risks

Coverage from The New York Times Wirecutter, Newsanyway, and others

DNA Testing Privacy Risks topic image

Direct-to-consumer DNA tests can reveal sensitive information about individuals and their relatives, while the companies handling that data may fall outside some traditional health-privacy protections.

Key concerns include opaque consent practices, sample and data retention, commercial sharing, re-identification, security breaches, vendor access, and law-enforcement matching. Companies such as 23andMe, AncestryDNA, and FamilyTreeDNA illustrate different questions around data use, deletion, and disclosure. The subject also involves the limits of HIPAA and GINA, state privacy rules, voluntary industry standards, and disputes over what happens to genetic data when a company is breached, sold, or faces financial distress.

Looking Back
11 Day Timeline
Jun 14Jun 16Jun 18Jun 20Jun 22Jun 24
All Articles2 articles
Important2 articles · CI Score 60 and above
The New York Times Wirecutter
A privacy guide in the USA explains how direct-to-consumer DNA testing companies handle genetic data amid limited federal rules, 2023 breach incidents, and differing law-enforcement access practices.
6/24/2026 • Personal Data & Identity • General
Newsanyway / Stuart Mackay
In April 2025, US states sought court action in the Eastern District of Missouri to halt 23andMe proposed genetic data sale during bankruptcy, citing privacy and security concerns.
6/14/2026 • Personal Data & Identity • General